Harald Löffler
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Research Interests
Harald Löffler has a total of 17 co-authors. Here are the top co-authors by number of shared publications:
C. Kosel
SLS-Kliniken GmbH
1 shared publication- Christoph Skudlik
University of Osnabrück
1 shared publication - Claudia Pföhler
Department of Dermatology, University Hospital Homburg/Saar, 66421 Homburg Saar, Germany
1 shared publication - Claudia Schröder-Kraft
Institute for Interdisciplinary Dermatologic Prevention and Rehabilitation (iDerm) at the University of Osnabrueck and Dermatologic Centre, Trauma Hospital
1 shared publication - Detlef Becker
Hautklinik, Universitätsmedizin Mainz
1 shared publication - Elke Weisshaar
Sektion Berufsdermatologie, Zentrum Hautklinik, Universitätsklinikum Heidelberg, Ruprecht-Karls Universität Heidelberg, Heidelberg, Deutschland
1 shared publication
Latest Publications
- Open Access
- 12 January 2026
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106
Molecular Classification in a Cohort of Occupational Dermatological Patients: Diagnostic Results and Course of Ability to Work and Sick Leave Over Two Years
Hand eczema is the most common occupational skin disease (OSD), often leading to sick leave or job termination. Standard diagnostic procedures are often ambiguous. Molecular classification has been described to improve differentiation between eczema and psoriasis, which is the most common differential diagnosis. Since 2020, a cohort of 287 patients with suspected, occupational hand and/or foot dermatoses (eczema or psoriasis) has been established in Germany. The current analysis focuses on descriptive results on the days of absence from work, occupational retention and legal recognition of OSD after 24 months. A total of 38.9% of the patients did not receive a distinct clinical diagnosis, while molecular diagnostics provided results in 93.1% of these cases. Sick leave days significantly decreased over 2 years (p<0.005) from a mean of 28.7 to 8.2 days. Legal recognition of OSD tripled from 10.1% to 30.2%. Job terminations due to skin diseases reached 27.1%, primarily from job changes or unemployment. Molecular diagnostics enhance diagnostic precision and may support improved prevention and disease management, reducing sick leave. The findings underscore the individual severity and social impact of skin diseases like eczema and psoriasis in high-risk employments.
- 12 January 2026
- Published by Medical Journals Sweden AB in Acta Dermato-Venereologica
- Vol. 106
Open AccessMolecular Classification in a Cohort of Occupational Dermatological Patients: Diagnostic Results and Course of Ability to Work and Sick Leave Over Two Years
Hand eczema is the most common occupational skin disease (OSD), often leading to sick leave or job termination. Standard diagnostic procedures are often ambiguous. Molecular classification has been described to improve differentiation between eczema and psoriasis, which is the most common differential diagnosis. Since 2020, a cohort of 287 patients with suspected, occupational hand and/or foot dermatoses (eczema or psoriasis) has been established in Germany. The current analysis focuses on descriptive results on the days of absence from work, occupational retention and legal recognition of OSD after 24 months. A total of 38.9% of the patients did not receive a distinct clinical diagnosis, while molecular diagnostics provided results in 93.1% of these cases. Sick leave days significantly decreased over 2 years (p<0.005) from a mean of 28.7 to 8.2 days. Legal recognition of OSD tripled from 10.1% to 30.2%. Job terminations due to skin diseases reached 27.1%, primarily from job changes or unemployment. Molecular diagnostics enhance diagnostic precision and may support improved prevention and disease management, reducing sick leave. The findings underscore the individual severity and social impact of skin diseases like eczema and psoriasis in high-risk employments.
- 28 April 2022
- Published by Springer Nature
- p. 633-644
Skin Changes Induced by Alcohol, Drug-Dependency, and Smoking
- 28 April 2022
- Published by Springer Nature
- p. 633-644
Skin Changes Induced by Alcohol, Drug-Dependency, and Smoking
- 27 March 2020
- Published by Springer Nature
- p. 1-12
Skin Changes Induced by Alcohol, Drug-Dependency, and Smoking
- 27 March 2020
- Published by Springer Nature
- p. 1-12
Skin Changes Induced by Alcohol, Drug-Dependency, and Smoking
- 27 May 2018
- Published by Springer Nature
- p. 633-646
Hautveränderungen durch Alkohol, Drogen und Rauchen
- 27 May 2018
- Published by Springer Nature
- p. 633-646
Hautveränderungen durch Alkohol, Drogen und Rauchen
- 16 May 2017
- Published by Springer Nature
- p. 1-14
Hautveränderungen durch Alkohol, Drogen und Rauchen
- 25 October 2009
- Published by Springer Nature in Die Dermatologie
- Vol. 60 (12) , 1013-1016
Die Propranolol-Therapie in der Behandlung problematischer Hämangiome
Aus kleinen Hämangiomen entstehen manchmal recht große Befunde. Je nach Lokalisation kann nicht immer eine lokale Therapie durchgeführt werden. Bei einem in der medizinischen Literatur beschriebenen Säugling hatte sich ein Hämangiom unter kardiologisch indiziertem Propranolol zurückgebildet. Diese Erfahrung wurde seitdem mehrfach genutzt und Propranolol mit der Indikation eines Hämangioms eingesetzt. Bisher kam es darunter selbst bei sehr ausgedehnten Hämangiomen meist zu einer schnellen Verbesserung. Auch nach Absetzen blieb der Erfolg erhalten. Gerade bei Problemlokalisationen wie in Augennähe ist ein schneller Therapieerfolg wichtig, um einer Erblindung vorzubeugen. Studien dazu sind in Vorbereitung. Small hemangiomas sometimes produce large findings. Depending on localization, local therapy is not always possible. According to a case described in the literature, a hemangioma in an infant regressed following cardiologically indicated Propranolol. This experience has been used in numerous other cases since then and Propranolol has been administered for the indication of a hemangioma. Even in cases of very large hemangiomas rapid improvement has been observed; successful results persisted even after discontinuation. Particularly in cases of problematic localisation, such as in the eye area, prompt therapeutic success is important in order to prevent blindness. Relevant studies are in the preparatory phase.
- 25 October 2009
- Published by Springer Nature in Die Dermatologie
- Vol. 60 (12) , 1013-1016
Die Propranolol-Therapie in der Behandlung problematischer Hämangiome
Aus kleinen Hämangiomen entstehen manchmal recht große Befunde. Je nach Lokalisation kann nicht immer eine lokale Therapie durchgeführt werden. Bei einem in der medizinischen Literatur beschriebenen Säugling hatte sich ein Hämangiom unter kardiologisch indiziertem Propranolol zurückgebildet. Diese Erfahrung wurde seitdem mehrfach genutzt und Propranolol mit der Indikation eines Hämangioms eingesetzt. Bisher kam es darunter selbst bei sehr ausgedehnten Hämangiomen meist zu einer schnellen Verbesserung. Auch nach Absetzen blieb der Erfolg erhalten. Gerade bei Problemlokalisationen wie in Augennähe ist ein schneller Therapieerfolg wichtig, um einer Erblindung vorzubeugen. Studien dazu sind in Vorbereitung. Small hemangiomas sometimes produce large findings. Depending on localization, local therapy is not always possible. According to a case described in the literature, a hemangioma in an infant regressed following cardiologically indicated Propranolol. This experience has been used in numerous other cases since then and Propranolol has been administered for the indication of a hemangioma. Even in cases of very large hemangiomas rapid improvement has been observed; successful results persisted even after discontinuation. Particularly in cases of problematic localisation, such as in the eye area, prompt therapeutic success is important in order to prevent blindness. Relevant studies are in the preparatory phase.
- 1 October 2008
- Published by Elsevier in Journal of Hospital Infection
- Vol. 70, 44-48
Hand disinfection: How irritant are alcohols?
- 1 October 2008
- Published by Elsevier in Journal of Hospital Infection
- Vol. 70, 44-48
Hand disinfection: How irritant are alcohols?
- 1 November 2004
- Published by Wiley in Contact Dermatitis
- Vol. 51 (5-6) , 259-262
The MOAHLFA index of irritant sodium lauryl sulfate reactions: first results of a multicentre study on routine sodium lauryl sulfate patch testing
In a multicentre study of the German Contact Dermatitis Research Group, sodium lauryl sulfate (SLS) 0.25% and 0.5% aq. has been added to routine allergen patch tests to assess its properties as a convenient diagnostic indicator of individual susceptibility to irritation at the time of patch testing. Previous studies indicated that irritant SLS reactivity may be related to individual factors such as age and sex. As these factors are, in turn, among the important predictors of contact allergy to many allergens, e.g. summarized in the ‘MOAHLFA index’, the impact of the MOAHLFA factors on irritant SLS patch test reactivity, and thus a potential for confounding, was assessed in the 5971 participating patients. As a result of 2 logistic regression analyses with an irritant reaction to 0.25% and 0.5% SLS, respectively, as outcome, male sex was identified as a relatively weak but significant risk factor (OR 1.38), while age 40 years or older was an even weaker risk factor (OR 1.22 and 1.15, respectively). Upon detailed analysis, no clear age gradient could, however, be identified. 1‐day exposure time almost halved the odds of an irritant SLS reaction. In conclusion, this type of SLS patch test can be regarded as robust, indicating individual irritability relatively independent from the individual factors analysed here.
- 1 November 2004
- Published by Wiley in Contact Dermatitis
- Vol. 51 (5-6) , 259-262
The MOAHLFA index of irritant sodium lauryl sulfate reactions: first results of a multicentre study on routine sodium lauryl sulfate patch testing
In a multicentre study of the German Contact Dermatitis Research Group, sodium lauryl sulfate (SLS) 0.25% and 0.5% aq. has been added to routine allergen patch tests to assess its properties as a convenient diagnostic indicator of individual susceptibility to irritation at the time of patch testing. Previous studies indicated that irritant SLS reactivity may be related to individual factors such as age and sex. As these factors are, in turn, among the important predictors of contact allergy to many allergens, e.g. summarized in the ‘MOAHLFA index’, the impact of the MOAHLFA factors on irritant SLS patch test reactivity, and thus a potential for confounding, was assessed in the 5971 participating patients. As a result of 2 logistic regression analyses with an irritant reaction to 0.25% and 0.5% SLS, respectively, as outcome, male sex was identified as a relatively weak but significant risk factor (OR 1.38), while age 40 years or older was an even weaker risk factor (OR 1.22 and 1.15, respectively). Upon detailed analysis, no clear age gradient could, however, be identified. 1‐day exposure time almost halved the odds of an irritant SLS reaction. In conclusion, this type of SLS patch test can be regarded as robust, indicating individual irritability relatively independent from the individual factors analysed here.